Cysview Blue Light Cystoscopy Registry
H
Hristos Kaimakliotis, MD
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
100 participants needed
3 Locations
Brief description of study
What is the purpose of this study?
The purpose of this registry is to study the use of BLCC in clinical practice in the United States and to allow researchers access to this data to look at different clinical questions. The goal is to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Detailed description of study
What will happen during the study?
- The Blue Light Cystoscopy with Cysview Registry is a web-based program supported by Global Vision Technologies.
- Data will be captured on specific patient types undergoing Blue Light Cystoscopy with Cysview for known or suspected non-muscle invasive bladder cancer.
- Data will be captured longitudinally over five (5) years on patients from each enrolled site.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Invasive Bladder Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria
- Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
- Or undergoing surveillance cystoscopy for carcinoma of the bladder
Exclusion Criteria
- Polyphyria
- Gross Hematuria
- Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives
Updated on
01 Aug 2024.
Study ID: 1903222683, BLCC
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
